Basics Genelux Corporation Common Stock IPO Date: January 26, 2023 Sector: Healthcare Industry: Biotech Market Cap: $176.56M Activated in VL: True Average Daily Range Avg Daily Range: $0.50 | 4.89% Avg Daily Range (30 D): $0.30 | 4.84% Avg Daily Range (90 D): $0.20 | 3.98% Institutional Daily Volume Avg Daily Volume: .13M Avg Daily Volume (30 D): .26M Avg Daily Volume (90 D): .17M Trade Size Avg Trade Size (Sh.): 96 Avg Trade Size (Sh.) (30 D): 99 Avg Trade Size (Sh.) (90 D): 108 Institutional Trades Total Inst.Trades: 29 Avg Inst. Trade: $3.39M Avg Inst. Trade (30 D): $.8M Avg Inst. Trade (90 D): $1.06M Avg Inst. Trade Volume: .24M Avg Inst. Trades (Per Day): 1 Market Closing Trades Avg Closing Trade: $6.61M Avg Closing Trade (30 D): $3.23M Avg Closing Trade (90 D): $3.23M Avg Closing Volume: 413.66K     News Sep 3, 2024 @ 8:01 PM Genelux Corporation to Present at the H.C. Wainwri... Source: N/A Jul 30, 2024 @ 11:00 AM Genelux Corporation to Participate in Fireside Cha... Source: N/A May 31, 2024 @ 4:01 PM Unveiling 4 Analyst Insights On Genelux Source: Benzinga Insights May 24, 2024 @ 12:00 PM Genelux Corporation Announces Pricing of Approxima... Source: Genelux Corporation May 23, 2024 @ 8:01 PM Genelux Corporation Announces Proposed Public Offe... Source: Genelux Corporation Financials   TTM Q3 2025 Q2 2025 Basic EPS $-.88 $-.21 $-.2 Diluted EPS $-.88 $-.21 $-.2 Revenue $ M $ M $ M Gross Profit $ $ $ Net Income / Loss $ -31.87M $ -7.95M $ -7.46M Operating Income / Loss $ -33.55M $ -8.19M $ -7.79M Cost of Revenue $ $ $ Net Cash Flow $ -1.41M $ -1.85M $ -9.66M PE Ratio